10.1097/01.hjr.0000277984.31558.c4
Allender S, 2008, European cardiovascular disease statistics, 2008
Lopez A, 2006, Lancet, 367, 1747, 10.1016/S0140-6736(06)68770-9
Pyörälä K, 1994, Eur Heart J, 15, 1300, 10.1093/oxfordjournals.eurheartj.a060388
Wood D, 1998, Eur Heart J, 19, 1434, 10.1053/euhj.1998.1243
De Backer G, 2003, Eur J Cardiovasc Prev Rehabil, 10, S1, 10.1177/174182670301000101
EUROASPIRE Study Group., 1997, Eur Heart J, 18, 1569, 10.1093/oxfordjournals.eurheartj.a015136
EUROASPIRE Study Group., 2001, Eur Heart J, 22, 554, 10.1053/euhj.2001.2610
EUROASPIRE Study Group., 2001, Lancet, 357, 995, 10.1016/S0140-6736(00)04235-5
Kotseva K, Wood D, De Backer G, De Bacquer D, Wilson K, Pyörälä K, Keil U, for the EUROASPIRE Study Group., 2009, Lancet, 373, 929, 10.1016/S0140-6736(09)60330-5
Wilson K, 2000, Arch Intern Med, 160, 939, 10.1001/archinte.160.7.939
Bucher HC, 2002, Am J Med, 112, 298, 10.1016/S0002-9343(01)01114-7
Taylor R, 2004, Am J Med, 116, 682, 10.1016/j.amjmed.2004.01.009
Klein S, 2004, Circulation, 110, 2952, 10.1161/01.CIR.0000145546.97738.1E
Flack J, 1995, Circulation, 92, 2437, 10.1161/01.CIR.92.9.2437
Law M, 2003, Health Technol Assess, 7, 1, 10.3310/hta7010
Cholesterol Treatment Trialists' (CTT) Collaboration., 2005, Lancet, 366, 1267, 10.1016/S0140-6736(05)67394-1
Bartnik M, 2004, Eur Heart J, 25, 1880, 10.1016/j.ehj.2004.07.027
Löwel H, 2000, Diabetologia, 43, 218, 10.1007/s001250050032
Malmberg K, 2000, Circulation, 102, 1014, 10.1161/01.CIR.102.9.1014
McGuire DK, 2000, Eur Heart J, 21, 1750, 10.1053/euhj.2000.2317
Mukamal KJ, 2001, Diabetes Care, 24, 1422, 10.2337/diacare.24.8.1422
Gustafsson I, 2000, Eur Heart J, 21, 1937, 10.1053/euhj.2000.2244
Gaede P, 2003, N Engl J Med, 348, 383, 10.1056/NEJMoa021778
Antithrombotic Trialists' Collaboration., 2002, BMJ, 324, 71, 10.1136/bmj.324.7329.71
Freemantle N, 1999, B/WJ, 318, 1730
Latini R, 1995, Circulation, 92, 3132, 10.1161/01.CIR.92.10.3132
Domanski MJ, 1999, J Am Coll Cardiol, 33, 598, 10.1016/S0735-1097(98)00609-3
ACE Inhibitor Myocardial Infarction Collaborative Group., 1998, Circulation, 97, 2202, 10.1161/01.CIR.97.22.2202
EURORA Investigators., 2003, Lancet, 362, 782, 10.1016/S0140-6736(03)14286-9
Blood Pressure Lowering Treatment Trialists' Collaboration., 2003, Lancet, 362, 1527, 10.1016/S0140-6736(03)14739-3
Anand SS, 1999, JAMA, 282, 2058, 10.1001/jama.282.21.2058
Bhatt DL, 2006, JAMA, 295, 180, 10.1001/jama.295.2.180
Mendis S, 2005, Bulletin World Health Organization, 83, 820
De Velasco JA, 1997, Rev Esp Cardiol, 50, 406, 10.1016/S0300-8932(97)73242-1
De Velasco JA, 2002, Rev Esp Cardiol, 55, 801, 10.1016/S0300-8932(02)76708-0
Danchin N, 2003, Ann Cardiol Angeiol, 52, 1, 10.1016/S0003-3928(02)00181-6
Ž Reiner, 2006, Eur J Cardiovasc Prev Rehab, 13, 646, 10.1097/01.hjr.0000183910.59741.96
Muntner P, 2006, Am J Epidemiology, 163, 913, 10.1093/aje/kwj124
Qureshi AI, 2001, Arch Intern Med, 161, 1621, 10.1001/archinte.161.13.1621
Khot UN, 2003, JAMA, 290, 898, 10.1001/jama.290.7.898
Ghandehary H, 2008, Am Heart J, 156, 112, 10.1016/j.ahj.2008.03.005
Fonarow G, 2001, Circulation, 103, 38, 10.1161/01.CIR.103.1.38
Pearson T, 2000, Arch Intern Med, 160, 459, 10.1001/archinte.160.4.459
Fox KAA, 2000, Eur Heart J, 21, 1440, 10.1053/euhj.2000.2185
Fox KAA, 2002, Eur Heart J, 23, 1177, 10.1053/euhj.2001.3081
Van Ganse E, 2005, Curr Med Res Opinion, 21, 1389, 10.1185/030079905X59139
Heidrich J, 2005, Eur J Cardiovasc Prev Rehab, 12, 521
Hobbs R, 2002, Earn Practice, 19, 596
Giannuzzi P, 2003, Eur Heart J, 24, 1273, 10.1016/S0195-668X(03)00198-2
Wood DA, 2008, Lancet, 371, 1999, 10.1016/S0140-6736(08)60868-5
